A scoping review: Treatment attitudes and adherence for adults with schizophrenia

Abstract

Aim and objectives This scoping review presents an exploration of literature on the relationship between treatment attitudes and adherence in adults experiencing schizophrenia. Background Strategies to address adherence and improve treatment outcomes are described in literature. However, adherence remains a challenge for people experiencing mental illness in practice. Transformational frameworks, evidence‐based practice and patient‐centred approaches have been established and implemented but non‐adherence incidence rates continue to rise among people with schizophrenia. Moreover, the relationship between treatment attitudes and adherence in adults diagnosed with schizophrenia remains unclear. Design A scoping review using the framework offered by Implementation Science, 5, 2010, 1. The PRISMA‐ScR checklist was used to ensure integrity of the review. Methods Four databases PsychINFO, Medline, Cochrane and CINAHL databases were searched for literature along with the reference lists of eligible sources. Original research, peer‐reviewed articles published between 2010 and 2020 in English language were included. Articles were included if study participants were adults with a diagnosis of schizophrenia or related psychosis. Methodological quality was evaluated using a quality assessment checklist, the Critical Appraisal Skills Programme tool. Results Ten articles were included in the study. Five main themes about treatment adherence emerged from the literature: (i) severity of symptoms, (ii) side effects, (iii) beliefs and attitudes, (iv) insight and (v) support and relationships. Conclusions This scoping review concluded that attitude influenced adherence to medication in people with schizophrenia. The five main themes reported directly influenced attitude, impacting on treatment adherence in people experiencing schizophrenia. This review makes recommendations for a person‐centred and recovery framework that aims to improve adherence. Relevance to clinical practice Nurses in all healthcare settings could use evidence‐based strategies to enhance treatment adherence in people with a range of physical and mental health conditions.

Attitude Toward Treatment and Medication Adherence Among Chronic Schizophrenia After Undergoing Confinement

“…In this study, the respondents who suffered from side effects of the drugs are more likely to be non-adherence to medication. The side effects of the drug cause the patients to feel drowsiness, headache, and movement problem [14]. The study also reported that participants did not have adequate support from families.…”

Therapeutic Adherence of People with Mental Disorders: An Evolutionary Concept Analysis

“…In all analyzed studies, the process of adherence is dynamic rather than static, involving objective and subjective personal experiences characterized by the ability to establish interpersonal skills [33]. At the individual level, this process includes the patient's readiness to change and motivation for mental health treatment [34][35][36][37], their medication literacy (readiness to understand the role of medication, how to use it, what works for each person, ability to reflect on past experiences and its effects) [3,34,36,[38][39][40], illness/symptom experience [41][42][43], coping and interpersonal skills [33,44], self-care ability [33,43], and self-efficacy [36,37,45].…”

“…(a) Family involvement and social support [39,40,48,51,58]; (b) Patient and family ongoing support [42,48,61]; (c) Mutual support groups [46,59,60];…”

Effects of empowerment‐based illness management on the medication adherence and recovery of persons with schizophrenia: A systematic review and meta‐analysis

“…Wen-Ling Hsieh 1,2 | I-Hsien Li 1,3 | Wen-I Liu 1 recovery of individuals' disease process (Caqueo-Urízar et al, 2021;Nyanyiwa et al, 2022;Pennington & McCrone, 2018;Vega et al, 2021).…”

“…The clinical guidelines of the American Psychiatric Association indicate that pharmacotherapy is the treatment approach with the highest level of evidence in terms of effectiveness compared to other approaches (Keepers et al, 2020). However, medication adherence in persons may be interrupted by numerous factors, including symptom severity, side effects of drugs, medication attitude, insight, and support system, resulting in a non‐adherence rate of 58.2%, which is associated with high medical and social costs, affecting the progression and recovery of individuals' disease process (Caqueo‐Urízar et al, 2021; Nyanyiwa et al, 2022; Pennington & McCrone, 2018; Vega et al, 2021).…”